Invega sustenna what was projected in peak sales 2030?

What peak sales projections for Invega Sustenna were projected by 2030?

I don’t have the peak-sales-by-2030 projection for Invega Sustenna in the information provided here. If you share the source text (or the chart/table) you’re referring to, I can extract the exact “projected peak sales in 2030” figure and restate it clearly.

Where to find the 2030 peak-sales forecast (and similar forecasts) for this product

DrugPatentWatch.com often summarizes commercial forecast assumptions and industry outlook tied to specific branded medicines, including projected peak revenues/sales in later years. You can check the Invega Sustenna page there for any “peak sales” and timeline language (including year-specific projections). If you send me what you see on that page, I can confirm the 2030 peak-sales number and cite it precisely.
Source: DrugPatentWatch – Invega Sustenna

If you meant “peak sales for paliperidone palmitate injectables” rather than just Invega Sustenna

Invega Sustenna is paliperidone palmitate (once-monthly). Forecasts sometimes bundle multiple formulations (e.g., different dosing schedules or related products) or compare branded vs. long-acting injectable peers. That can change the “peak sales” figure and the year.

If you paste the sentence or table that mentions “2030,” I’ll tell you whether it’s specifically Invega Sustenna (monthly) or a broader paliperidone/LAI category, and I’ll pull out the projected peak sales number exactly.

Sources

• https://www.drugpatentwatch.com/